WJPPS Citation

Login

Search

News & Updation

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

  • WJPPS: MAY ISSUE PUBLISHED
  • MAY 2026 Issue has been successfully launched on 1 MAY 2026.

Abstract

APPLICATIONS OF R PROGRAMMING IN PHARMACOMETRICS: A SIMULATION-BASED POPULATION PHARMACOKINETIC CASE STUDY

Dr. Zunera Fatima, Dr. Syed Afzal Uddin Biyabani*

ABSTRACT

Pharmacometrics is a core component of model-informed drug development, integrating pharmacokinetics, pharmacodynamics, and computational modelling to characterize drug disposition, quantify variability, and optimize dosing strategies. The growing use of simulation-based methods has strengthened the role of computational platforms such as R in pharmacometrics analysis, enabling robust modelling, stochastic simulation, and reproducible quantitative workflows. In this short communication, an R-based population pharmacokinetic simulation framework was applied to evaluate the impact of interindividual variability on drug exposure under repeated dosing conditions. Using a one-compartment model with first-order elimination, 200 virtual subjects were simulated with variability in elimination rate constants incorporated through a log-normal distribution. Variability in concentration–time profiles and exposure metrics, including Cmax and AUC, was assessed. The simulations demonstrated substantialvariability in systemic exposure despite identical dosing, highlighting the influence of pharmacokinetic heterogeneity on therapeutic outcomes. These findings underscore the utility of simulation-driven pharmacometrics modelling and support the application of R in individualized dosing and model-informed precision therapeutics.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More